Molina Healthcare, Inc. (MOH) Stock Analysis 2026

HealthcareHealthcare Plans
$207.36
as of 2026-10-16
+16.0% (52-week)50D MA $210.84  |  200D MA $176.10

BriMind AI Score

Proprietary
46
Neutral
Price CAGR
13.4%
1Y Return
+1.5%
Analyst Upside
+6.2%
Rev Growth
-5.7%

Score based on historical price CAGR, revenue growth, analyst upside, and valuation factors. Updated daily.

AI scores and price targets are for informational and educational purposes only. They do not constitute financial advice or a recommendation to buy or sell any security. Past performance is not indicative of future results. Always conduct your own research before making investment decisions. Full Disclaimer →

MOH Revenue & Profitability Breakdown

This chart shows how MOH's revenue flows through to profit. Each row deducts a layer of costs: first the direct cost of making products/services (Cost of Revenue), then operating expenses like marketing and R&D, then taxes. What remains at the bottom is net income — the actual profit shareholders own. High gross and net margins indicate a business with strong pricing power and efficiency.

Revenue
$42.47B
Cost of Revenue
-$38.89B
Gross Profit
$3.58B8.4% margin
Operating Expenses
-$2.99B
Operating Income
$593.7M1.4% margin
Tax & Other
-$600.5M
Net Income
-$-6.8M-0.0% margin
Gross Margin
8.4%
Operating Margin
1.4%
Net Margin
-0.0%
EBITDA Margin
4.6%

Key Financial Metrics

Molina Healthcare, Inc. trades at a trailing P/E of 1250.00x, generates $700.2M in free cash flow, runs a debt/equity ratio of 94.77, and converts shareholder equity into profit at a -0.2% return on equity. For context: P/E ratio measures how much you pay for $1 of earnings (lower = cheaper, but fast-growing companies command higher P/E); Free Cash Flow is the cash left after running the business; Debt/Equity shows how leveraged a company is; Return on Equity shows how efficiently it turns shareholder capital into profit.

Market Cap
$10.44B
Enterprise Value
$10.56B
P/E (Trailing)
1250.00
P/E (Forward)
20.53
PEG Ratio
1.78
EV / EBITDA
5.75
Price / Sales
0.40
Price / Book
3.72
Revenue
$42.47B
Revenue Growth
-5.7%
Earnings Growth
-75.3%
EBITDA
$1.84B
Gross Margin
8.4%
Operating Margin
1.4%
Net Margin
-0.0%
Return on Equity
-0.2%
Return on Assets
1.2%
Free Cash Flow
$700.2M
Total Cash
$9.29B
Total Debt
$3.77B
Debt / Equity
94.77
Current Ratio
1.68
Quick Ratio
1.61
Beta
0.75
Dividend Yield
None
Payout Ratio
0.0%
Insider Ownership
1.4%
Inst. Ownership
111.5%
Short % Float
6.2%
Book Value / Share
$80.21

Wall Street Analyst Consensus

14 analysts covering Molina Healthcare, Inc. currently lean toward a Hold rating, with a mean 12-month price target of $209.12 (+0.8% vs the current price). Analysts set these targets after researching a company's earnings, competitive position, and industry trends — Strong Buy / Buy means the majority expect meaningful upside, while Hold means fair value near the current price rather than a sell signal.

Consensus RatingHold(14 analysts)
SellStrong Buy
Low Target$291.0040.3%
Mean Target$209.12+0.8% upside
High Target$414.00+99.7%

Intrinsic Value Estimates for MOH

We use 1 valuation model to estimate MOH's intrinsic value. Intrinsic value is what a stock is truly worth based on the company's fundamentals, independent of what the market prices it at today. If multiple models agree the stock is undervalued, that convergence is a stronger signal.

Technical Price Signals

MOH is currently in a short-term downtrend, trading below its 50-day average of $210.84 and above its 200-day average of $176.10. Moving averages smooth out day-to-day volatility to reveal the underlying trend — a Golden Cross (50MA crosses above 200MA) is a classic bullish signal, a Death Cross is bearish, though both are lagging indicators that confirm trends rather than predict them.

Current Price
$207.36
50-Day MA
$210.84
▼ Price below
200-Day MA
$176.10
▲ Price above
Short-term Downtrend
Below 50-day MA — caution
Read the full MOH in-depth report
Seven-method valuation, AI Score, blended price target, and a 5-year Monte Carlo simulation for MOH.

Compare MOH with Peers

CNC vs MOHCentene vs Molina Healthcare — Two Medicaid-Focused Man
HCA vs MOHHCA Healthcare vs Molina Healthcare — Hospital Provider
MOH vs CVSMolina Healthcare vs CVS Health — Medicaid Specialist v
MOH vs IDXXMolina Healthcare vs IDEXX Laboratories — Medicaid Mana
MOH vs ZTSMolina Healthcare vs Zoetis — Medicaid Managed Care vs
HUM vs MOHHumana vs Molina Healthcare — Medicare Advantage vs Med
MOH vs UNHMolina Healthcare vs UnitedHealth — Medicaid Specialist
ELV vs MOHElevance Health vs Molina Healthcare — Which Medicaid-F

More Healthcare Stock Analysis

In-depth reports on companies operating alongside MOH — business models, bull and bear cases, and the metrics that matter.

HUMHumana Inc.Healthcare PlansUNHUnitedHealth Group IncorporatedHealthcare PlansCVSCVS Health CorporationHealthcare PlansABBVAbbVie Inc.Drug Manufacturers - GeneralINSMInsmed IncorporatedBiotechnologyARCTArcturus Therapeutics Holdings Inc.BiotechnologyBEAMBeam Therapeutics Inc.BiotechnologyINCYIncyte CorporationBiotechnology

Unlock the Full MOH Analysis

Interactive price charts, real-time AI signals, advanced DCF models, portfolio tracking, earnings analysis, and side-by-side peer comparisons. Start your 14-day free trial — no credit card required.

Start Free TrialBrowse All Stocks
Data sources: Financial metrics and market data sourced from company SEC filings, earnings releases, and investor relations disclosures. Price data, analyst consensus targets, and fundamental financials provided by financial market data providers. ETF data sourced from official fund prospectuses and index provider publications. AI scores and price targets are proprietary estimates — see our Methodology and Disclaimer for details.
← Back to Home · Browse All Stock Analysis